Clorox (CLX) Down 3.7% Since Last Earnings Report: Can It Rebound?

A month has gone by since the last earnings report for Clorox (CLX). Shares have lost about 3.7% in that time frame, underperforming the S&P 500.Will the recent negative trend continue leading up to its next earnings release, or is Clorox due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.How Have Estimates Been Moving Since Then?It turns out, estimates review have trended upward during the past month.VGM ScoresCurrently, Clorox has an average Growth Score of C, though it is lagging a bit on the Momentum Score front with a D. Following the exact same course, the stock was allocated a grade of D on the value side, putting it in the bottom 40% for this investment strategy.Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.OutlookEstimates have been broadly trending upward for the stock, and the magnitude of these revisions looks promising. Notably, Clorox has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.Performance of an Industry PlayerClorox is part of the Zacks Consumer Products - Staples industry. Over the past month, Procter & Gamble (PG), a stock from the same industry, has gained 4.8%. The company reported its results for the quarter ended March 2025 more than a month ago.P&G reported revenues of $19.78 billion in the last reported quarter, representing a year-over-year change of -2.1%. EPS of $1.54 for the same period compares with $1.52 a year ago.For the current quarter, P&G is expected to post earnings of $1.42 per share, indicating a change of +1.4% from the year-ago quarter. The Zacks Consensus Estimate has changed -0.6% over the last 30 days.The overall direction and magnitude of estimate revisions translate into a Zacks Rank #4 (Sell) for P&G. Also, the stock has a VGM Score of D.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Clorox Company (CLX): Free Stock Analysis Report Procter & Gamble Company (The) (PG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks